Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2006-06-01
The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding
patterns (cycle control), general safety and acceptability of the nomegestrol
acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women
aged 18-50 years.
Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2006-05-01
The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding
patterns (cycle control), general safety and acceptability of the nomegestrol
acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women
aged 18-50 years.
Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2006-10-01
The primary purpose of this study is to evaluate the effects of the nomegestrol
acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) on ovarian function.
The Oral Contraceptive Pill for Premenstrual Worsening of Depression
Completed
Massachusetts General Hospital
N/A
2008-02-01
To determine if augmentation with the oral-contraceptive pill containing drospirenone and
ethinyl estradiol is more effective than placebo in the treatment of premenstrual
breakthrough of depression.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
